scispace - formally typeset
C

Christina H. Stuelten

Researcher at National Institutes of Health

Publications -  39
Citations -  3286

Christina H. Stuelten is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Transforming growth factor beta & Metastasis. The author has an hindex of 21, co-authored 36 publications receiving 2851 citations.

Papers
More filters
Journal ArticleDOI

Protection from obesity and diabetes by blockade of TGF-β/Smad3 signaling

TL;DR: It is demonstrated that TGF-β signaling regulates glucose tolerance and energy homeostasis and suggested that modulation of T GF-β activity might be an effective treatment strategy for obesity and diabetes.
Journal ArticleDOI

Cell motility in cancer invasion and metastasis: insights from simple model organisms

TL;DR: In this Review, insights relevant to human cancer that are derived from the study of cell motility in non-mammalian model organisms are evaluated, including the detailed signalling network that governs chemotaxis towards chemokines.
Journal ArticleDOI

Smad3 is key to TGF-β-mediated epithelial-to-mesenchymal transition, fibrosis, tumor suppression and metastasis

TL;DR: Focusing on models involving epithelial-to-mesenchymal transition (EMT), including injury to the lens and retina of the eye and to the kidney, it is found that loss of Smad3 blocks EMT and attenuates development of fibrotic sequelae.
Journal ArticleDOI

Extracellular Matrix Proteoglycans Control the Fate of Bone Marrow Stromal Cells

TL;DR: Biglycan and decorin appear to be essential for maintaining an appropriate number of mature osteoblasts by modulating the proliferation and survival of bone marrow stromal cells, and underscore the importance of the micro-environment in controlling the fate of adult stem cells.
Journal ArticleDOI

Breast cancer cells induce stromal fibroblasts to express MMP-9 via secretion of TNF-α and TGF-β

TL;DR: The results indicate that MMP-9 levels in tumor fibroblasts are regulated by a complex tumor-stroma cross-talk, involving multiple ligands and cellular signaling pathways.